Single-Cell Functional Proteomics Provides Predictive Product Potency Metrics in Metastatic Lung Cancer Combination Therapy

Genetic Engineering & Biotechnology NewsVol. 41, No. 11 Sponsored ContentSingle-Cell Functional Proteomics Provides Predictive Product Potency Metrics in Metastatic Lung Cancer Combination TherapyProvides Predictive Product Potency Metrics in Metastatic Lung Cancer Combination TherapyPublished Online:11 Nov 2021https://doi.org/10.1089/gen.41.11.02AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 41Issue 11Nov 2021 Information© 2021 by GEN PublishingTo cite this article:Single-Cell Functional Proteomics Provides Predictive Product Potency Metrics in Metastatic Lung Cancer Combination Therapy.Genetic Engineering & Biotechnology News.Nov 2021.10-10.http://doi.org/10.1089/gen.41.11.02Published in Volume: 41 Issue 11: November 11, 2021PDF download